Cancer Screening for Women Over 40: What's Worth Doing (2026 UK Guide)
- Chun Tang

- Mar 17
- 8 min read
Cancer screening for women over 40: what’s actually worth doing in 2026
Women over 40 face a screening landscape that’s better than men’s — NHS cervical and breast programmes do a lot of work — but still has meaningful gaps. Earlier mammography, ovarian and endometrial awareness, bowel and skin screening, and risk-based decisions all matter.
This guide is a practical plan. What to do, when, what costs to expect privately, and what to skip.
The short answer
A sensible cancer-focused screening plan for an average-risk woman over 40:
Cervical cancer: NHS cervical screening every 3–5 years as invited
Breast cancer: mammogram from 40–50 (NHS from 50, private earlier if you want)
Bowel cancer: ColoAlert or FIT from 40–50
Skin cancer: annual visual examination
Lung cancer: low-dose CT if smoking history, age 55–80
Ovarian and endometrial: symptom awareness rather than blind screening
Comprehensive blood panel annually after 40
Family history, BRCA status, ethnic background, and HRT decisions all alter this baseline meaningfully. Adjust accordingly.
What the NHS offers women
For context, NHS routine screening for women:
Cervical cancer screening: every 3 years 25–49, every 5 years 50–64 (HPV-based screening since 2019)
Breast cancer screening: mammogram every 3 years from 50–71
Bowel cancer screening (FIT): every 2 years from 50 (being lowered)
No routine screening for: ovarian, endometrial, pancreatic, kidney, skin, lung (unless eligible for targeted CT programme)
That’s substantial — particularly cervical and breast screening — but leaves gaps under 50 and in cancers without screening programmes.
Cervical cancer screening
The single most important screen on this list. The NHS programme has dramatically reduced cervical cancer deaths since introduction. Take it.
What to do:
Accept every NHS smear invitation
Age 25–49: every 3 years
Age 50–64: every 5 years
HPV-positive results may prompt earlier repeat
Private smear available if you want it sooner than NHS schedule (£150–£300)
HPV vaccination reduces but does not eliminate cervical cancer risk. Continue screening even if vaccinated.
Symptoms that should not wait for screening: - Bleeding between periods - Bleeding after sex - Postmenopausal bleeding (any amount, any time, ever) - Unusual vaginal discharge - Pelvic pain
Any postmenopausal bleeding is a red flag and needs urgent investigation.
Breast cancer screening
Why it matters: 1 in 7 UK women diagnosed in their lifetime. Survival heavily dependent on stage at diagnosis.
What to do:
Age 40–49: consider private mammograms every 1–2 years. NHS doesn’t routinely screen this age group.
Age 50–71: accept NHS mammogram every 3 years. Consider private mammogram in between if you want more frequent screening.
Age 71+: NHS stops inviting. Continue private mammograms every 1–2 years if well.
Dense breasts: add ultrasound to mammogram for better sensitivity
High risk (BRCA, family history): annual MRI plus mammogram from 30
Self-examination: monthly, throughout adult life. Know your normal so you spot what’s different.
Cost: - Mammogram: free on NHS 50–71, £150–£350 privately - Ultrasound: £150–£300 - Breast MRI: £500–£900 (mostly for high-risk surveillance)
See our private breast cancer screening guide for full detail.
Bowel cancer screening
Why it matters: the second-most common cancer killer in UK women. Often missed because symptoms blend in with other gut issues.
What to do:
Age 40–49: ColoAlert or FIT every 2 years if average risk, annually if family history
Age 50+: accept NHS FIT. Consider ColoAlert in between for better sensitivity
Symptoms (blood, change in habit, weight loss): GP visit, not screening test
Cost: - FIT: free on NHS from 50, £30–£50 privately if younger - ColoAlert: £350–£450
See our bowel cancer symptoms guide.
Skin cancer screening
Why it matters: UK skin cancer rates are rising. Women often catch lesions earlier than men because they’re more attuned to skin changes — but blind spots exist.
What to do:
Monthly self-examination — head to toe, including scalp, soles, between toes, back
Partner involvement or mirror for hard-to-see areas
Annual professional examination by GP or dermatologist
Anything new, changing, bleeding, itching: see a GP
ABCDE for moles: - Asymmetry - Border irregular - Colour uneven - Diameter over 6mm - Evolving over weeks/months
Cost: - GP visual exam: included in routine appointments - Dermatologist mole mapping: £150–£400
Lung cancer screening
Why it matters: rising in women, often in never-smokers. Most cases present late.
What to do:
Never smokers, no exposure: no routine screening
Current or former smokers: low-dose CT from age 55–80
Accept any NHS targeted lung health check invitation
Persistent cough over 3 weeks, particularly with weight loss or bleeding: see a GP
Cost: - NHS targeted programme: free where available - Private low-dose CT chest: £200–£400
Ovarian cancer — no good screening test, but symptoms matter
The big challenge with ovarian cancer is the absence of a useful screening test for the general population. CA125 and pelvic ultrasound combined have been studied extensively and don’t improve survival as a population screen.
What to do instead — know the symptoms:
Persistent bloating that doesn’t settle
Feeling full quickly when eating
Pelvic or abdominal pain
Needing to urinate more urgently or frequently
Change in bowel habit
Unexplained weight loss or fatigue
These are common symptoms with many causes. Persistent versions (more than 12 days a month) deserve a GP visit, examination, blood test (CA125 in this clinical context) and pelvic ultrasound.
For high-risk women (BRCA, strong family history): - Specialist gynaecology surveillance with transvaginal ultrasound and CA125 - Consider risk-reducing salpingo-oophorectomy (preventive ovary and tube removal) after completing family
Endometrial (womb) cancer — symptom awareness
Like ovarian, there’s no good population screening test. Symptoms are the alarm.
Red flag: any postmenopausal bleeding. Any spotting, any amount, any time after menopause needs urgent investigation. About 10% of postmenopausal bleeding turns out to be endometrial cancer; the other 90% deserves investigation too.
In premenopausal women: heavy or irregular bleeding warrants investigation if persistent, particularly with risk factors (obesity, PCOS, diabetes, family history, Lynch syndrome).
Investigation typically includes: pelvic ultrasound, sometimes endometrial biopsy or hysteroscopy.
HRT and cancer risk — a nuanced conversation
Many women over 40 face decisions about HRT, and the cancer implications need clear information:
HRT slightly raises breast cancer risk over several years of use, with the risk being modest in absolute terms
HRT lowers bowel cancer risk and may lower endometrial cancer risk if combined HRT is appropriate
The risk-benefit calculation is individual — symptoms severity, age, family history, baseline health
Continue mammography on HRT, ideally every 1–2 years
The Women’s Health Initiative scare of the 2000s overstated risks for many women. Modern HRT decisions should be based on current evidence, not 20-year-old headlines.
Genetic testing and BRCA
Women with significant family cancer history should consider genetic counselling. Particularly:
Two or more relatives with breast or ovarian cancer
Any relative with both breast and ovarian cancer
Any male breast cancer in the family
Ashkenazi Jewish heritage with any breast or ovarian cancer history
Breast cancer diagnosed under 50 in a close relative
BRCA1/BRCA2 carriers face significantly elevated lifetime risk of breast (up to 70%) and ovarian cancer (10–40%), and have specific surveillance options including annual MRI screening from 30 and consideration of risk-reducing surgery.
See our family history of cancer guide.
Useful annual blood tests for women over 40
A well-designed annual blood panel for women 40+:
Full blood count
Iron studies — important for women, particularly with menstrual blood loss
Liver and kidney function
HbA1c (diabetes)
Lipid profile
Vitamin D
Vitamin B12 and folate
Thyroid function
Calcium and bone profile (relevant around menopause)
CA125 in symptomatic women only — not as routine screening.
Cost: £100–£250 for a comprehensive panel.
This is more useful than a generic “cancer marker panel” — see our tumour marker guide.
A practical annual schedule for women 40+
Every year: - Full annual blood screen - Skin self-examination plus professional check - Breast self-examination (monthly really, plus annual GP/specialist exam) - BP, weight, lifestyle review
Every 1–3 years: - Cervical smear (per NHS schedule) - Mammogram (every 1–2 years from 40–50, NHS every 3 years from 50–71)
Every 1–2 years: - ColoAlert or FIT (private from 40 if family history, NHS FIT from 50)
Every 1–2 years for smokers/ex-smokers 55–80: - Low-dose CT chest
One-off: - Genetic counselling if significant family cancer history - Discussion of HRT, family planning, menopause as relevant
Things worth doing besides screening
A cancer prevention plan for women 40+ includes:
Don’t smoke
Keep alcohol low (alcohol is a clearer breast cancer risk factor in women than the public realises)
Maintain a healthy weight
Exercise regularly
Maintain bone density (calcium, vitamin D, weight-bearing exercise)
HPV vaccination if eligible
Discuss HRT individually with proper risk assessment
Sun protection
Breastfeeding (where applicable) modestly reduces breast cancer risk
Hormonal contraception decisions in BRCA carriers need specialist input
These move risk more than most screening tests.
A realistic private screening package for women 40+
A sensible private women’s health screen might include:
30-minute GP consultation, full history including reproductive and family
Comprehensive blood panel
Breast examination and discussion of mammography schedule
ColoAlert
Skin examination
Resting ECG, BP
Pelvic examination if appropriate
HRT discussion if relevant
Discussion of HPV vaccination, smear schedule
Total cost: £400–£800 depending on inclusions.
Add a mammogram (£200–£350) and you’ve covered most of the screening that actually matters for around £600–£1,000.
What to skip
Whole-body MRI as a routine screen — high false positive rate, misses key cancers
CA125 in asymptomatic women — not a useful screening test
Generic “cancer marker panels” — don’t replace proper screening
Annual chest X-ray in non-smokers — no evidence of benefit
Routine pelvic ultrasound in asymptomatic average-risk women — not effective screening
Frequently asked questions
At what age should I start having “the works” each year? 40 is reasonable for annual private GP consultation with bloods, especially if family history. Many women find their late 40s and early 50s are when cancer awareness ramps up — start the conversation then.
Can I get all of this on the NHS? Most of the cervical, breast, and bowel screening yes. The earlier private breast screening, faster investigations, ColoAlert, and annual comprehensive review is the gap private fills.
What about home screening kits? ColoAlert and FIT are validated. Direct-to-consumer hormone and tumour marker tests are mixed in usefulness without clinical interpretation.
My mum had breast cancer at 65. What’s my risk? Slightly elevated but probably not into “high-risk” territory. A GP risk assessment using validated tools can give you an actual percentage. Mammography from 40 is reasonable.
Should I have a smear during menopause if I’m not sexually active? Yes — HPV exposure can have been years or decades ago. Continue per NHS schedule until 64 unless specifically advised otherwise.
Does the contraceptive pill cause cancer? Modern combined pills slightly increase breast cancer risk during use, reduce ovarian and endometrial cancer risk substantially, and risk normalises a few years after stopping. The overall picture is balanced for most women.
What’s the most overlooked screen? Skin examination of back, scalp, and other hard-to-see areas. Partner or professional involvement helps.
In summary
Cancer screening for women over 40 is well-supported by NHS programmes for cervical and breast cancer, with gaps that private screening can sensibly fill: earlier mammography, ColoAlert for bowel cancer, comprehensive blood panels, skin examination, and lung CT for smokers.
The most important interventions aren’t tests but health behaviours: not smoking, moderate alcohol, healthy weight, regular movement, plus knowing the symptoms that should never be ignored (any postmenopausal bleeding, persistent abdominal symptoms, new breast lump, new skin lesion that changes).
Build a screening plan with a clinician who knows your full picture. The right tests at the right times beat the most expensive package any day.
About the author
Dr Chun Tang (MBChB, MRCGP, MBA) is a GMC-registered private GP and co-founder of Northwest Health in Bamber Bridge, Preston. His clinical interests include cancer screening and preventive medicine. He has been featured in The Daily Telegraph, The Mirror, SheerLuxe, BBC and GB News.
Ready to put a screening plan in place?Book a private GP consultation for a personalised women’s health and cancer screening review.

Comments